Objective-Excessive caloric intake is associated with obesity and adipose tissue dysfunction. However, the role of dietary cholesterol in this process is unknown. 
O besity has reached epidemic proportions worldwide. In the United States, 67% of adults (>20 years) are overweight (≥25 kg/m 2 body mass index) or obese (≥30 kg/m 2 body mass index), resulting in medical care costs of $147 billion in 2008. 1, 2 Obesity increases the risk of other chronic diseases, such as type 2 diabetes mellitus, coronary heart disease, insulin resistance, and nonalcoholic fatty liver disease. 3 Adipocytes are active endocrine cells that secrete adipokines, store excess energy as triglyceride, release fatty acids during fasting states, and control systemic glucose disposal. 4 During progression of obesity, fat cell size increases because of triglyceride accretion. 5 Larger adipocytes exhibit decreased responsiveness to insulin, decreased glucose uptake, and increased secretion of proinflammatory adipokines. [6] [7] [8] [9] Enlarged adipocytes are associated with macrophage infiltration into adipose tissue, resulting in increased production of proinflammatory cytokines and insulin resistance. 10 Diets high in calories, saturated fat, and cholesterol (ie, Western diets) are sufficient to cause obesity in humans and in experimental animals. 3, 5 However, the role of individual dietary constituents, particularly dietary cholesterol, in the development of obesity is poorly understood.
Adipose tissue is a major site for cholesterol storage in humans. 11 In obese states, approximately half of the wholebody pool of cholesterol is stored in adipose depots. Because adipocyte hypertrophy occurs during development of obesity, cholesterol content also increases. 12 Adipocytes are unique among cells in that nearly all cholesterol (>93%) is stored in the unesterified form (ie, free cholesterol [FC] ) and nearly all of the adipocyte FC (≈88%) is distributed on the triglyceride droplet surface, with the remainder located in the plasma membrane. 13, 14 Dietary cholesterol worsened adipose tissue inflammation in a mouse model of diet-induced obesity, suggesting that high dietary cholesterol can lead to adipocyte dysfunction. 5 Whether dietary cholesterol leads to adipocyte hypertrophy and dysfunction in humans is unknown and is a difficult question to address experimentally.
To address this gap in knowledge, we studied the effect of dietary cholesterol on adipocyte size, adipose tissue cholesterol content, and gene/protein expression in a nonhuman primate atherosclerosis model. We chose this model because of its close phylogenetic relationship with humans and because lipid and lipoprotein responses to a Westerntype atherogenic diet in nonhuman primates mimic human responses better than rodent models. 15 In addition, dietary composition is more easily controlled than in humans, and tissues are readily available for subsequent analyses. Here, we demonstrate that increasing dietary cholesterol alone was sufficient to drive adipocyte hypertrophy specifically in visceral fat, with increased adipose tissue FC and inflammatory gene expression in nonhuman primates. Results from this study suggest a role for dietary cholesterol in increasing adipocyte dysfunction, a characteristic feature of the pathogenesis of obesity.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Dietary Cholesterol Increases Plasma Very Low-Density Lipoprotein and LowDensity Lipoprotein Cholesterol
To examine the effect of increasing levels of dietary cholesterol on plasma lipids and lipoprotein concentrations in African green monkeys, 3 isocaloric Western-type diets containing 35% fat with 0.002 (low [Lo]), 0.2 (medium [Med]), or 0.4 (high [Hi] ) mg cholesterol/kcal were fed to monkeys. During the 10-week diet feeding period, no significant difference was observed in food consumption (data not shown), body weight ( Figure 1A ), or plasma triglyceride concentrations ( Figure 1B ). However, there was a striking increase in plasma total cholesterol concentrations for the Hi cholesterol group (P<0.0001) relative to the Med and Lo groups, which was apparent after 3 weeks ( Figure 1C ). The increase in plasma total cholesterol was, in part, attributable to a significant increase in very low-density lipoprotein (VLDL) cholesterol ( Figure 1D ) but was primarily attributable to large increases in LDL cholesterol ( Figure 1E ). Plasma high-density lipoprotein cholesterol concentrations were not affected by increasing dietary cholesterol ( Figure 1F ).
The effects of increasing dietary cholesterol on intestinal cholesterol absorption, cholesterol excretion, and hepatic lipid content were also examined ( Table 1 ). The percentage of dietary cholesterol absorption was similar among all 3 diet groups (average of 52%-56%). Fecal cholesterol excretion increased in a stepwise manner with increasing dietary cholesterol. In addition, there was a significant increase of hepatic FC (P=0.0001) and cholesteryl ester (P=0.001) content with increasing dietary cholesterol, caused primarily by large increases in the Hi cholesterol group. Hepatic triglyceride content trended higher with increasing dietary cholesterol, but there were no significant differences among the diet groups; there was also no visible evidence of hepatic steatosis by histological examination of liver sections ( Figure I in the online-only Data Supplement). We also observed changes in hepatic gene expression that were compatible with the increase in hepatic cholesterol content (Table 2) . Specifically, sterol regulatory element binding protein 2 (SREBP2) and HMGCR mRNA expression decreased, whereas ABCG1 expression increased (ABCA1 also trended upward). Several studies suggest that adipose cholesterol accumulation correlates with an increased risk for metabolic syndrome and cardiovascular diseases. 16, 17 However, it is unclear whether dietary cholesterol directly affects adipose tissue cholesterol accumulation and, if so, whether dietary cholesterol accumulation differs among adipose depots. To address this question, we measured cholesterol levels in omental and in subcutaneous adipose tissue. Dietary cholesterol intake ≤0.4 mg cholesterol/kcal had no significant effect on subcutaneous adipose tissue total cholesterol, FC, or esterified cholesterol content ( Figure 2A , 2B, and 2C, respectively). By contrast, omental fat total cholesterol and FC contents were significantly increased in monkeys fed the Hi versus Lo cholesterol diet ( Figure 2D -2E). Omental fat cholesteryl ester content was low (<10% of total cholesterol) and did not vary among diet groups ( Figure 2F ). To determine whether dietary cholesterol altered adipocyte hypertrophy in a depot-specific manner, we examined adipocyte size by analyzing digital images of hematoxylin and eosin-stained paraffin sections from omental and subcutaneous adipose tissue. Consistent with cholesterol accumulation, adipocyte size increased with increasing dietary cholesterol in omental fat ( Figure 3A Figure 3C ). Collectively, these data demonstrated that increasing dietary cholesterol in monkeys selectively drives increases in adipose tissue cholesterol content and adipocyte size in omental fat. There was also Gene expression was determined by quantitative real-time polymerase chain reaction, and results were normalized to GAPDH. Results were then normalized to the mean value for each gene in the Lo-chol group, which was set to a value of 1. Mean±SEM, n=5 per diet group. ns indicates not statistically significant. 
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Dietary Cholesterol Is Associated With Omental Adipose Tissue Inflammation
To determine whether the increase of omental fat cholesterol content induced by dietary cholesterol altered endocrine function, we examined adipokine gene expression by quantitative real-time polymerase chain reaction. There was a significant increase in the expression of the proinflammatory genes interleukin-6 and interleukin-8 in the Hi cholesterol diet group relative to the other groups ( Figure 4A ). Tumor necrosis factor-α gene expression trended upward with increasing dietary cholesterol but did not reach statistical significance (P=0.065). Next, we examined macrophage gene expression in omental adipose tissue. There was a significant upregulation of macrophage recruitment-associated genes, including monocyte chemoattractant protein-1, C-C chemokine receptor type 2, and the macrophage marker CD68, in Hi versus Lo cholesterol diet groups ( Figure 4B ). We observed no increase in M2 type macrophage gene expression ( Figure IIIA Figure 4C ). In addition, plasma levels of glucose, insulin, or adiponectin were similar among diet groups (Figure VII in the online-only Data Supplement) and tumor necrosis factor-α levels were undetectable, indicating that 10 weeks of atherogenic diet feeding did not impair insulin sensitivity or systemic inflammation. These data suggest that increasing dietary cholesterol intake promotes adipose tissue inflammation and recruitment of macrophages into omental fat, but in the absence of body weight differences among diet groups does not lead to systemic insulin resistance.
Next, we determined whether an increase in omental fat FC content altered expression of genes involved in cholesterol biosynthesis and cellular cholesterol uptake and efflux ( Figure 5 ). SREBP2, a master regulator of cholesterol biosynthesis, was unaffected by dietary cholesterol ( Figure 5A ). However, the expression of HMG (3-hydroxy-3-methyl-glutaryl)-CoA reductase, the rate-limiting enzyme for cholesterol biosynthesis, was significantly reduced in Med and Hi cholesterol diet groups when compared with that in the Lo cholesterol group ( Figure 5A ). In addition, VLDL receptor and LDL receptor (LDLr) gene expressions were significantly lower in the Med and Hi groups when compared with those in the Lo cholesterol group ( Figure 5B ). Scavenger receptor class B type I showed a decreasing trend with increasing dietary cholesterol (P=0.076). LDLr-related protein gene expression level did not differ among diet groups.
To determine the effect of dietary cholesterol on cholesterol efflux pathways, we analyzed expression of several genes and proteins involved in adipocyte cholesterol efflux. 18, 19 Adipose tissue ABCA1 and ABCG1 mRNA expression was similar among diet groups, but apolipoprotein E (apoE) expression levels tended to increase with increasing dietary cholesterol (P=0.12; Figure 5C 
Discussion
Adipose tissue is the largest FC storage site in the body, and its cholesterol content affects gene expression and cellular function. 20, 21 However, it is unclear whether dietary cholesterol has a direct effect on adipocyte size, cholesterol content, and metabolic function. The fundamental question addressed in our study was whether increasing dietary cholesterol drives adipocyte hypertrophy and inflammation and, if so, whether it occurs in a fat depotspecific manner. Increasing dietary cholesterol (from 0.002 to 0.4 mg/kcal) was associated with a selective increase in cholesterol content and adipocyte size in omental adipose tissue; these relationships were not observed in subcutaneous fat (Figures 1-3) . Our data also revealed that increased visceral fat cholesterol content induced by Hi cholesterol diet feeding promoted increased expression of genes associated with adipose tissue inflammation and macrophage recruitment (Figure 4) , with cytokine expression primarily associated with CD68-positive cells (Figures IV-VI in the online-only Data Supplement). These changes occurred in the absence of significant differences in body weight among monkeys consuming the 3 levels of dietary cholesterol. Collectively, our work shows that increasing dietary cholesterol alone is sufficient to induce adipocyte hypertrophy and adipose tissue inflammation selectively in visceral fat of nonhuman primates.
Whether dietary cholesterol, per se, can affect adipocyte hypertrophy and inflammation is unknown. Obesity results from excess caloric consumption that often includes increased dietary 
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September 2014 cholesterol intake and is associated with adipocyte hypertrophy and increased recruitment of macrophages into adipose tissue. 10 Enlarged adipocytes are insulin resistant, secrete more proinflammatory cytokines, and have greater basal and catecholamine-stimulated lipolysis than smaller adipocytes. [6] [7] [8] [9] 22 Fat cell hypertrophy is associated with increased adipocyte cholesterol in humans 13, 23 and rodents, 24 but whether this occurs passively with adipocyte triglyceride accumulation during progression of obesity or actively induces adipocyte hypertrophy is unknown.
Past studies have yielded conflicting results about the role of dietary cholesterol on adipocyte size and cholesterol content. Angel and Farkas 24 documented an increase in rat adipocyte cholesterol with increasing dietary cholesterol load (0.05%-5%); however, rats fed a cholesterol-free diet had more cholesterol in adipocytes than those fed diets containing 0.05% or 0.1% cholesterol, suggesting a complex relationship between dietary cholesterol intake and adipocyte sterol homeostasis. In one study, Subramanian et al 5 fed Ldlr knockout mice a high-fat (60% cal), high carbohydrate (26% cal) diet with (0.15%) or without added cholesterol (0.03% from lard in the diet) and showed that added dietary cholesterol resulted in macrophage infiltration into epididymal fat (ie, visceral fat depot) but did not increase adipocyte size. However, inguinal (ie, subcutaneous fat depot) fat cells were increased in size with added dietary cholesterol, but macrophage infiltration was not observed. Kovanen et al 12 reported that a high-cholesterol diet failed to increase adipocyte cholesterol in rats but did increase plasma and hepatic cholesterol concentrations. No study to date has examined the inter-relationships between dietary cholesterol intake and adipocyte size, adipose tissue cholesterol content, and inflammatory status.
In this study, we demonstrate that feeding nonhuman primates diets that were identical except for increasing level of cholesterol was sufficient to increase visceral fat cell size and adipose tissue cholesterol and macrophage content. Furthermore, these increases were not observed in subcutaneous fat and occurred in the absence of body weight differences among diet groups. The difference in our outcomes (increased visceral adipocyte size, cholesterol and macrophage content with increasing dietary cholesterol) from those of Subramanian et al 17 (increased visceral fat macrophage content, but not size) are likely related to the animal model (monkey versus Ldlr knockout mice) and diet composition. Our diets are typical of the North American diet in total fat content (35% cal) and fatty acid composition (enriched in saturated and monounsaturated fat). The Hi cholesterol diet is equivalent to consumption of 3 to 4 eggs/d for a 2000 to 2500 calorie/d diet, which might be consumed by individuals at risk of developing obesity and coronary heart disease. To our knowledge, this is the first study to show that elevated dietary cholesterol in a typical North American diet can induce adipocyte hypertrophy and inflammation in nonhuman primates. Thus, high dietary cholesterol intake may be one causal factor in the development of adipose tissue hypertrophy and inflammation that accompanies obesity, insulin resistance, and type 2 diabetes mellitus. Although we did not observe systemic insulin resistance in our study, likely because of similar body weights among our groups of nonhuman primates, a longer feeding period may have resulted in hyperglycemia and hyperinsulinemia.
The increased visceral fat cholesterol content in monkeys fed the Hi cholesterol diet likely occurred through increased uptake of cholesterol from plasma VLDL and LDL. Supporting this idea, the Hi cholesterol diet significantly elevated plasma VLDL and LDL cholesterol concentrations (Figure 1) , and we observed a significant correlation between plasma LDL cholesterol concentrations and omental adipocyte size ( Figure II in the online-only Data Supplement). Most cells respond to an increase in FC by converting excess FC to cholesteryl ester via acyl CoA:cholesterol acyltransferase, decreasing de novo cholesterol biosynthesis, decreasing lipoprotein uptake via downregulation of the LDLr, and increasing efflux of cholesterol via ABCA1, ABCG1, and scavenger receptor class B type I. 25 Adipocytes are unusual in that >95% of cellular cholesterol is FC, and most of their FC is located on the surface of the lipid droplet. [12] [13] [14] All of these cellular responses to excess FC are mediated by 2 master transcriptional factors, SREBP2 26 and liver X receptor (LXR), 27 which prevent cholesterol uptake/ synthesis and stimulate FC efflux, respectively. In our study, visceral fat from Hi cholesterol-fed monkeys had 50% more FC when compared with monkeys fed the Lo cholesterol diet. On the basis of visceral fat gene expression ( Figure 5 ; Figure  IIIG -IIII in the online-only Data Supplement), cholesterol biosynthetic (HMGCR), lipoprotein receptor (LDLr and VLDL receptor), and fatty acid oxidation (PPARα and ACOX) gene expression were downregulated, suggesting that the visceral fat tissue was attempting to compensate for increased FC content. We 18 and others 19 have shown that ABCA1 expression is critical in the regulation of adipocyte FC content in mice. Although gene expression of LXR-responsive genes involved in FC efflux was unaltered by diet ( Figure 5C ), ABCA1 and apoE protein expression was significantly higher in Hi versus Lo cholesterol groups ( Figure 5D ), suggesting that efflux of FC likely plays a critical role in regulating adipocyte sterol homeostasis in nonhuman primates as well. Thus, although increased plasma cholesterol has not been associated with increased adipocyte cholesterol in all studies, 24, 28 it is the most likely explanation for increased visceral fat cholesterol in this one.
Visceral fat is more metabolically active and susceptible to dysfunction relative to subcutaneous fat. 29 In our study, subcutaneous fat did not respond to increased dietary cholesterol intake with a change in fat cell size, adipose tissue FC content, or inflammatory cytokine expression. Interestingly, adipocyte size and adipose tissue cholesterol content were 50% greater for subcutaneous versus visceral fat in monkeys consuming the Lo cholesterol diet (Figures 2 and 3) . Feeding monkeys the Hi cholesterol diet increased visceral fat cell size and adipose tissue cholesterol content to levels observed for subcutaneous fat. These results suggest that large fat cell size or adipose tissue cholesterol content, per se, does not result in inflammation and dysfunction. The reason for the metabolic differences between visceral versus subcutaneous fat that lead to divergent responses to increased dietary cholesterol is unknown and will require further investigation.
In conclusion, we provide the first evidence that addition of cholesterol to a typical North American diet selectively induces visceral adipocyte enlargement, adipose tissue cholesterol accumulation, and inflammatory responses in nonhuman primates. Visceral fat cells seem to compensate for increased dietary cholesterol by limiting cholesterol uptake/synthesis and increasing FC efflux pathways. Our results establish new metabolic inter-relationships between dietary cholesterol and adipocyte hypertrophy, adipose tissue cholesterol accumulation, and inflammation that may explain part of the metabolic dysfunction that accompanies diet-induced obesity. Although our study did not specifically address reducing dietary cholesterol as a means of lowering the risk of adipocyte hypertrophy and dysfunction, we speculate that this might be the case. If so, recommending a prudent intake of dietary cholesterol could potentially be a simple strategy to reduce adipocyte hypertrophy and dysfunction in humans.
